O-PCE, also known as 2′-Oxo-PCE, is a dissociative compound belonging to the arylcyclohexylamine class. It functions primarily as an NMDA receptor antagonist, producing altered states of consciousness, detachment from the physical self, and changes in sensory perception. Originally synthesized for research purposes, O-PCE has gained popularity in psychonautical and neuropharmacological studies due to its potency, unique effect profile, and structural similarity to substances like ketamine and MXE.

• Chemical Classification: O-PCE is categorized as an arylcyclohexylamine, a group known for dissociative effects through NMDA receptor antagonism. This class includes related compounds like PCP, 3-MeO-PCP, and Ketamine.

• Mechanism of Action: O-PCE binds to NMDA receptors in the brain, blocking glutamate activity. This disrupts the normal flow of sensory input and cognition, leading to dissociation, analgesia, and altered perception of time and body.

• Effect Profile: Its effects range from mild cognitive detachment at low doses to intense ego-dissolution and body-mind separation at higher doses. It is widely appreciated for producing introspective and “out-of-body” experiences.

• Duration and Potency: With an average active window of 4–8 hours, O-PCE is known for its extended dissociative plateau and strong potency even at low milligram doses.

• Form and Appearance: Typically available in crystalline or powdered form, it is odorless, tasteless, and easy to handle in controlled research environments.

• Legal Grey Area: Though not internationally scheduled, O-PCE may be regulated under analogue acts or local substance control laws in certain jurisdictions.

• Primary Uses: Most commonly used in neuropharmacological research, consciousness studies, or experimental comparison with other dissociatives for academic or independent exploration.

The legality of O-PCE varies significantly across countries and jurisdictions. It is generally considered a grey-market substance, meaning it’s not explicitly scheduled under international treaties but may still be controlled under analog or psychoactive substance laws depending on location. As with all research chemicals, buyers are responsible for understanding their regional laws before purchasing.

• Not Listed in International Schedules: O-PCE is not classified under the United Nations Convention on Psychotropic Substances or the Controlled Substances Act in some countries, allowing for legal import and sale in certain areas.

• Controlled Under Analogue Laws: In countries like the U.S., O-PCE may be regulated under analogue legislation if it is deemed structurally or pharmacologically similar to a scheduled drug such as PCP.

• Local and Regional Bans: Several EU member states and Asian countries have specific bans or controls on O-PCE or similar arylcyclohexylamines. It’s crucial to verify legality before placing an order.

• Legal for Research Use: In many places, O-PCE is permitted for scientific, analytical, or educational purposes, provided it is not sold or consumed for recreational use.

• No Prescription Required on Psycho Plug: We do not require a prescription, but we only ship to locations where the product is legally permitted. Orders to banned areas will be canceled and refunded.

• Customs Risk Consideration: If O-PCE is seized by customs in a region where it’s restricted, we offer options for reshipment or refund, depending on policy compliance.

• Responsibility of the Buyer: Buyers must ensure that importing or possessing O-PCE complies with local laws. Psycho Plug does not assume legal responsibility for misuse or unlawful import.

Proper storage of O-PCE is essential to maintain its chemical stability, potency, and usability for long-term research. As a crystalline powder sensitive to moisture and heat, it should be stored under lab-safe conditions in airtight, light-resistant containers. Incorrect storage can lead to clumping, degradation, or loss of efficacy.

• Temperature Control: O-PCE should be kept in a cool environment, ideally between 2–8°C. While room temperature is acceptable short-term, refrigeration extends shelf life.

• Humidity Protection: Moisture is one of the biggest threats to O-PCE’s stability. Use airtight containers with desiccant packs to prevent humidity damage.

• Light Exposure: Prolonged light exposure can cause photochemical breakdown. Store in amber or opaque containers to minimize this risk.

• Air Exposure: Limit exposure to air, especially oxygen. Oxidation can subtly alter the chemical structure and reduce effectiveness.

• Storage Materials: Glass vials with sealed screw caps are preferred. Plastic bags may allow for air exchange over time, reducing efficacy.

• Avoid Contamination: Always use clean tools (e.g., sterile scoop or spatula) when measuring O-PCE to prevent introducing impurities.

• Labeling for Safety: Ensure containers are clearly labeled with compound name, purity, date received, and storage guidelines. This helps avoid confusion and accidental misuse.

O-PCE produces a wide spectrum of dissociative effects that vary depending on dosage, method of administration, and individual physiology. These effects are primarily cognitive and perceptual, often involving detachment from the body and environment, altered sensory input, and distorted time perception. It is valued by researchers for inducing profound non-ordinary states of consciousness.

• Dissociation: The hallmark effect of O-PCE is the sensation of detachment from one’s physical body or immediate surroundings. This can range from mild (observer state) to extreme (complete disembodiment).

• Time Distortion: Users report significant changes in the perception of time, with minutes feeling like hours or vice versa, especially at peak doses.

• Cognitive Displacement: Thought patterns become abstract, non-linear, or introspective. This may enhance philosophical or metaphysical inquiry in research contexts.

• Sensory Modulation: Sight, sound, and touch may become blurred, delayed, or altered. Some experience auditory hallucinations or geometric visual overlays.

• Anxiolysis and Emotional Flattening: At moderate doses, O-PCE can reduce anxiety and blunt emotional responses, creating a neutral or emotionally flat state.

• Motor Impairment: High doses interfere with balance, coordination, and verbal ability. For safety, users should be seated or supervised during trials.

• Aftereffects: Following the primary experience, users may feel mentally “foggy,” sedated, or deeply introspective for several hours.

In research environments, O-PCE is primarily used to study NMDA receptor antagonism and its impact on consciousness, perception, and neuroplasticity. Researchers and experimentalists employ O-PCE for both observational and comparative pharmacological studies, often in relation to other dissociatives.

• Neuropharmacology: O-PCE is studied to understand how it inhibits glutamate transmission via NMDA receptor binding, which plays a key role in learning and memory.

• Consciousness Studies: Due to its ability to decouple sensory processing from conscious awareness, it is used in experiments that examine ego dissolution and altered states.

• Comparative Analysis: Researchers compare O-PCE with compounds like ketamine or 3-MeO-PCP to evaluate differences in onset, duration, and cognitive effects.

• Dose-Response Modeling: Controlled trials are conducted to determine the minimum effective dose, threshold levels, and behavioral response curves.

• Toxicology Research: Long-term cell culture or organ-on-chip studies are used to examine the compound’s impact on neural cells or receptor systems.

• Analytical Chemistry: Labs use techniques like gas chromatography or mass spectrometry to analyze the purity and structure of O-PCE samples.

• Solubility and Formulation Testing: Studies may also explore O-PCE’s solubility in various solvents to prepare it for in-vitro research or solution-based analysis.

O-PCE is most commonly available in a crystalline or powdered form, making it suitable for precise measurement and research applications. This physical state allows for easy dissolution in solvents and ensures consistency in dosing for lab-based studies. It is rarely sold in capsules or pre-measured units due to the need for accurate microgram-level measurement.

• Crystalline Powder: The standard and most reliable form of O-PCE is a dry, fine crystalline powder. This offers excellent stability when stored properly and is easy to handle in controlled environments.

• Soluble for Solutions: While O-PCE is poorly soluble in water, it dissolves effectively in solvents like ethanol, DMSO, and propylene glycol. This makes it ideal for solution-based pharmacological research or analytical preparation.

• Freebase Form: Most O-PCE on the market is in freebase form, which affects how it behaves in different solvents and its absorption properties when tested in biological environments.

• No Premade Capsules: Psycho Plug does not sell O-PCE in capsule or tablet form, as these are often inconsistent and not conducive to precision research. Users should always measure with professional lab equipment.

• Appearance: Visually, it is a white to slightly off-white powder that is dry and odorless. Discoloration or clumping may indicate contamination or moisture damage.

• Custom Quantities Available: While we list standard amounts (250mg, 500mg, 1g, etc.), we also provide custom sizing options upon request for laboratories or institutions conducting specialized studies.

Although O-PCE and MXE (methoxetamine) belong to the same class of arylcyclohexylamines and share similar dissociative mechanisms, they are distinct compounds with different chemical structures, durations, and subjective effects. O-PCE is often compared to MXE due to its availability after MXE was banned, but the experience and pharmacological profiles differ in meaningful ways.

• Structural Differences: While both compounds are built around the arylcyclohexylamine framework, O-PCE lacks the methoxyethyl group that characterizes MXE. This alters their pharmacokinetics and receptor binding profiles.

• Duration and Potency: O-PCE typically lasts longer than MXE (4–8 hours vs. 3–5 hours) and is more potent by weight, meaning lower doses are needed to achieve similar levels of dissociation.

• Effect Profile: MXE is known for producing a warm, euphoric dissociation, while O-PCE tends to be colder, more introspective, and sometimes more cognitively intense.

• Availability and Legality: MXE has been widely banned across major jurisdictions due to recreational misuse. O-PCE remains in a legal grey area in many regions, making it more accessible for researchers today.

• Safety Profile: O-PCE does not share MXE’s known long-term toxicity (such as bladder issues), but due to its potency, overdose risk may be higher if not carefully measured.

• User Reports in Research: Many researchers find O-PCE less forgiving than MXE, requiring more caution and environmental control during trials.

• Role in Research: Both are used to study NMDA antagonism, consciousness alteration, and non-ordinary perception, though O-PCE has largely replaced MXE in current comparative studies.

O-PCE is a highly potent dissociative compound, often active at doses as low as 5–10 milligrams. Its strength means that improper measurement or misuse can easily lead to overwhelming or unpredictable effects. This level of potency makes it particularly valuable for microdosing studies and dose-response experiments, but it also requires strict safety protocols.

• Active Dose Range: Most users report noticeable dissociation effects starting at 5–10mg, with strong to intense experiences occurring above 15–25mg depending on the route of administration.

• Threshold Effects: Even doses as low as 2–3mg can produce mild detachment or cognitive shifts, making it useful for low-impact observational studies.

• Steep Dose Curve: O-PCE has a steep dose-response curve, meaning effects increase rapidly with small dosage increments. This can lead to sudden intensification if not carefully measured.

• Route of Administration Impact: Potency varies with route—oral, sublingual, or intranasal. Insufflation typically leads to a faster onset and stronger peak compared to oral intake.

• Measurement Precision Required: Researchers must use microgram-accurate digital scales. A deviation of even 1mg can make a significant difference in subjective intensity.

• High Affinity for NMDA Receptors: Its strong binding efficiency contributes to its psychoactive power, often producing complete sensory decoupling or ‘hole’ experiences at moderate to high doses.

• No Tolerance to Potency Over Time: Unlike some dissociatives, tolerance to O-PCE builds quickly, requiring escalating doses for the same effects, which may mask its true potency over time.

Like all powerful dissociatives, O-PCE carries a range of potential risks, especially when not handled with scientific precision or when used in uncontrolled environments. Its intense cognitive effects can impair judgment, memory, and coordination, which may lead to physical injury or psychological distress.

• Overdose Risk: Due to its potency, O-PCE can easily cause overdose if improperly measured. High doses may result in loss of motor function, complete detachment, or catatonia-like states.

• Cognitive Confusion: Users may experience disorganized thoughts, impaired memory recall, and temporary amnesia during and after use, complicating post-session analysis.

• Physical Coordination Impairment: O-PCE reduces motor control, increasing the risk of falls, injuries, or accidents in unsupervised settings.

• Psychological Disturbances: In some individuals, especially those with underlying mental health issues, O-PCE may induce paranoia, anxiety, or panic during the peak phase.

• Dependency Potential: While not physically addictive, psychological habituation can occur with frequent use, as users may become reliant on dissociative states to cope with stress or emotions.

• Long-Term Effects Unknown: Research on chronic exposure is limited, so long-term neurochemical impact remains uncertain. This warrants careful monitoring in repeated-trial studies.

• Interaction Dangers: Mixing O-PCE with alcohol, benzodiazepines, or stimulants can be dangerous, leading to respiratory depression, erratic behavior, or increased neurotoxicity.

The effects of O-PCE are known for their duration, intensity, and lingering aftereffects. Depending on the route of administration and dose, the experience can last several hours, with some psychological and perceptual aftershocks that persist into the next day. This makes O-PCE one of the longer-acting compounds in its class, requiring adequate time allocation in any research session.

• Onset Time: Effects typically begin within 15–30 minutes when taken orally, and within 5–15 minutes via intranasal insufflation.

• Peak Effects: Most intense effects are experienced between 1 to 3 hours after ingestion, characterized by strong dissociation and perceptual distortion.

• Total Duration: The primary psychoactive effects last between 4 to 8 hours, with the length increasing at higher doses or when redosed during the session.

• Residual Effects: After the peak, users may feel cognitively slowed, emotionally neutral, or physically drained for up to 12–24 hours.

• Influence of Tolerance: Regular users often report shorter durations due to receptor desensitization, while first-time users may experience a more prolonged state.

• Route-Dependent Variability: Oral use typically yields a slower onset and longer total effect, whereas nasal or sublingual routes may produce a faster but slightly shorter experience.

• Impact on Daily Functioning: Because of its lingering cognitive haze, it is not advisable to engage in important activities such as driving, academic tasks, or professional work for several hours post-use.

Mixing O-PCE with other substances can be extremely dangerous and is strongly discouraged in any context outside highly controlled laboratory research. Its powerful dissociative effects can become unpredictable or even life-threatening when combined with depressants, stimulants, or psychedelics. For accurate research data and safety, O-PCE should always be studied in isolation.

• Risk of Respiratory Depression: Combining O-PCE with central nervous system depressants like alcohol, benzodiazepines, or opioids can significantly suppress breathing and lead to unconsciousness or death.

• Unpredictable Interactions with Stimulants: Mixing O-PCE with stimulants such as amphetamines or cocaine may increase heart rate and blood pressure dangerously, while also causing agitation or paranoia.

• Psychedelic Synergy: Although some researchers are tempted to combine O-PCE with psychedelics like LSD or psilocybin, doing so may intensify hallucinations and cause confusion, anxiety, or loss of reality testing.

• Reduced Research Validity: Co-administering substances skews data in pharmacological studies, making it difficult to isolate the effects of O-PCE for accurate dose-response modeling.

• Increased Neurotoxicity Potential: Some combinations may increase neurotoxicity by overstimulating glutamatergic or dopaminergic systems. Long-term consequences are not fully understood.

• Seizure Risk: High doses or interactions with serotonergic drugs may lower the seizure threshold, especially in sensitive individuals.

• Loss of Self-Control: Polydrug use often impairs judgment, which is especially dangerous when using high-potency dissociatives like O-PCE that already diminish bodily awareness and coordination.

Accurate dosing of O-PCE is essential due to its high potency and steep response curve. Even a slight error in measurement can significantly alter its effect profile. For any legitimate research application, dosing must be done using professional-grade microgram scales in a safe and controlled environment.

• Threshold Dose (1–3mg): At this level, mild mental detachment or cognitive shifts may be observable, offering a baseline for receptor sensitivity studies.

• Light Dose (5–10mg): Produces noticeable but manageable dissociation, ideal for initial behavioral observation or receptor mapping trials.

• Common Moderate Dose (10–20mg): Brings about full dissociative effects suitable for consciousness research or comparative analysis with other NMDA antagonists.

• High Dose (20–30mg+): At this range, users may enter immersive dissociative states with significant motor impairment and perceptual decoupling. High caution is advised.

• Route-Dependent Potency: Insufflated doses act faster and often feel more intense than oral equivalents; researchers must adjust accordingly.

• Never Eyeball Doses: Given its fine crystalline texture, visual estimation is not only inaccurate but dangerous. Precision scales are non-negotiable.

• Titration Best Practices: When studying long-term effects, researchers should start with lower doses and increase incrementally across separate sessions to avoid unpredictable reactions.

While O-PCE does not appear to produce physical dependence in the way that opioids or stimulants do, it does carry a significant risk of psychological addiction, especially in unsupervised or recreational contexts. Its ability to induce escapism, introspection, and emotional numbing can create compulsive use patterns over time.

• Rapid Tolerance Build-Up: With repeated use, the brain quickly adapts to O-PCE, leading to reduced effects and increased dose requirements. This often leads to short-term bingeing.

• Psychological Dependence: Users may begin to rely on the dissociative state to avoid emotions, trauma, or stress, creating unhealthy coping mechanisms.

• Withdrawal Symptoms: Although not physical in nature, withdrawal can include depression, cognitive fog, emotional instability, and sleep disturbance.

• Habitual Craving: Especially in high-dose users, cravings to return to a dissociative state can interfere with daily functioning or responsibilities.

• Not Physically Addictive: Unlike substances that cause physical dependency (e.g., heroin, benzodiazepines), O-PCE does not cause traditional withdrawal syndromes like nausea or tremors.

• Behavioral Reinforcement: The introspective and novel mental landscapes created by O-PCE may reinforce repetitive use as users seek to revisit specific psychological insights or fantasies.

• Abuse Potential in Vulnerable Individuals: Those with a history of substance misuse, trauma, or emotional instability are at greater risk of developing a psychological relationship with the compound.

O-PCE and 3-MeO-PCP are both arylcyclohexylamine dissociatives, but they differ significantly in potency, effects, and applications in research. While both act as NMDA antagonists, their subjective effects diverge—O-PCE is more sedating and immersive, while 3-MeO-PCP is typically more stimulating and functional.

• Duration Comparison: O-PCE lasts approximately 4–8 hours, often with a slower onset, while 3-MeO-PCP has a shorter but more stimulating 4–6 hour active window.

• Effect Quality: O-PCE tends to be deeply dissociative, introspective, and sedating, making it suitable for ego-deconstruction studies. 3-MeO-PCP, on the other hand, can enhance alertness and is often described as “manic” or “functional.”

• Potency Differences: 3-MeO-PCP is slightly more potent by weight but easier to misdose due to its stimulating nature. O-PCE has a more gradual escalation in effects but is harder to tolerate at high doses.

• Cognitive Clarity vs. Immersion: 3-MeO-PCP is favored for research that requires some level of interaction or dialogue, while O-PCE is more suitable for deep sensory decoupling or dream-state exploration.

• Safety Profiles: Both carry significant risks if misused. 3-MeO-PCP is more likely to induce delusions or psychotic breaks at high doses; O-PCE leans toward motor suppression and amnesia.

• Legal Status: 3-MeO-PCP is controlled in more regions globally, while O-PCE is still legal or unscheduled in many countries, making it more accessible for legitimate research purposes.

• Neuropharmacological Focus: Both compounds are used in NMDA receptor studies, but O-PCE’s longer duration and sedative tendencies make it better for time-extended trials.

Handling O-PCE safely and effectively requires precision tools and safety protocols. Because of its high potency and potential health risks, researchers must use laboratory-grade instruments and adopt professional hygiene standards to avoid contamination, misdosing, or accidental exposure.

• Microgram Precision Scale: Essential for accurate dosing. A professional milligram or microgram scale (0.001g resolution or finer) is required to avoid mismeasurement.

• Nitrile Gloves: To prevent dermal absorption or accidental ingestion through contact. Nitrile offers superior resistance compared to latex.

• Lab-Grade Vials: Airtight, amber glass vials are preferred for storing and labeling samples. They prevent light degradation and contamination.

• Desiccant Packs: These help maintain a moisture-free environment inside storage containers, preserving the powder’s consistency and potency.

• Protective Eyewear and Mask: While not always necessary, in environments with frequent powder handling, masks can prevent inhalation and eye protection guards against accidental exposure.

• Measuring Tools: Sterile spatulas, micro-scoops, and solvent syringes may be used for solvent preparation or solubility trials.

• Secure Storage Cabinet: A lockable, temperature-controlled cabinet or chemical storage unit ensures safe keeping, away from unauthorized access or environmental threats.